Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
NeoplasmsPancreatic Neoplasms
Interventions
DRUG

Glufosfamide

DRUG

Gemcitabine

Trial Locations (9)

40202

Norton Healthcare Cancer Center, Louisville

46202

Indiana Cancer Center, Indianapolis

85724

Arizona Cancer Center, Tucson

34000-000

Hospital de Doenças Cardiovasculares - Biocor, Nova Lima

90880-480

Hospital Mãe de Deus, Porto Alegre

91350-200

Hospital Nossa Senhora da Conceição, Porto Alegre

14784-400

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos

04023-900

Universidade Federal de São Paulo - Hospital São Paulo, São Paulo

05651-901

Hospital Israelita Albert Einstein, São Paulo

Sponsors
All Listed Sponsors
lead

Threshold Pharmaceuticals

INDUSTRY

collaborator

PPD Development, LP

INDUSTRY